17,437 results match your criteria: "Vu University Medical Center[Affiliation]"

Article Synopsis
  • * The paper aims to help radiologists by discussing MRI protocols, workflows, and reporting practices for monitoring amyloid-related imaging abnormalities (ARIA).
  • * Key topics include FDA guidelines for ARIA evaluation, standard MRI sequences, patient imaging scenarios, the radiologist's role in treatment, and results from a 2023 survey on dementia imaging practices.
View Article and Find Full Text PDF

Long-Term Survival in Patients With Advanced Melanoma.

JAMA Netw Open

August 2024

Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Importance: Long-term survival data from clinical trials show that survival curves of patients with advanced melanoma treated with immune checkpoint inhibitors (ICIs) gradually reach a plateau, suggesting that patients have a chance of achieving long-term survival.

Objective: To investigate long-term survival in patients with advanced melanoma treated with ICIs outside clinical trials.

Design, Setting, And Participants: Cohort study using prospectively collected data from the nationwide Dutch Melanoma Treatment Registry, including patients in the Netherlands with advanced melanoma treated with first-line ICIs from 2012 to 2019.

View Article and Find Full Text PDF

Several conjugates between folic acid and a series of kinetically stable lanthanide complexes have been synthesized, using amide coupling and azide-alkyne cycloaddition methodologies to link the metal-binding domain to folate through a variety of spacer groups. While all these complexes exhibit affinity for the folate receptor, it is clear that the point of attachment to folate is essential, with linkage through the γ-carboxylic acid giving rise to significantly enhanced receptor affinity. All the conjugates studied show affinities consistent with displacing biological circulating folate derivatives, 5-methyltetrahydrofolate, from folate receptors.

View Article and Find Full Text PDF

The ethical dimension of personal health monitoring in the armed forces: a scoping review.

BMC Med Ethics

August 2024

Department of Ethics, Law and Humanities, Amsterdam UMC, Location VU University Medical Center, De Boelelaan 1089a, 1081 HV, Amsterdam, The Netherlands.

Background: Personal Health Monitoring (PHM) has the potential to enhance soldier health outcomes. To promote morally responsible development, implementation, and use of PHM in the armed forces, it is important to be aware of the inherent ethical dimension of PHM. In order to improve the understanding of the ethical dimension, a scoping review of the existing academic literature on the ethical dimension of PHM was conducted.

View Article and Find Full Text PDF

: The difference in incidence and severity of anti-PD-1 therapy-related adverse events (irAEs) between adjuvant and advanced treated melanoma patients remains unclear, as no head-to-head studies have compared these groups. : This multi-center cohort study analyzed melanoma patients treated with anti-PD-1 in adjuvant or advanced settings between 2015 and 2021. Comorbidities and ECOG performance status were assessed before treatment, and grade III-IV irAEs were monitored during treatment.

View Article and Find Full Text PDF

The aperiodic exponent of neural activity varies with vigilance state in mice and men.

PLoS One

August 2024

University of Groningen, Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands.

Recently the 1/f signal of human electroencephalography has attracted attention, as it could potentially reveal a quantitative measure of neural excitation and inhibition in the brain, that may be relevant in a clinical setting. The purpose of this short article is to show that the 1/f signal depends on the vigilance state of the brain in both humans and mice. Therefore, proper labelling of the EEG signal is important as improper labelling may obscure disease-related changes in the 1/f signal.

View Article and Find Full Text PDF

Introduction: Transgender women are at increased risk of acquiring HIV. Earlier studies reported lower retention in HIV care, antiretroviral therapy uptake, adherence and viral suppression. We assessed the stages of the HIV care continuum of transgender women in the Netherlands over an 11-year period.

View Article and Find Full Text PDF
Article Synopsis
  • - Lesch-Nyhan Disease (LND) is a rare genetic disorder caused by mutations in a specific gene, resulting in neurological issues like abnormal movement and self-harm, which are hard to treat.
  • - A systematic review of 34 studies found that many had high bias, and there were significant differences in how treatments were applied and evaluated, leading to inconsistent results.
  • - The most researched treatments, such as S-Adenosylmethionine and Deep Brain Stimulation, need more investigation, and there is a pressing need for better study designs to improve the assessment of treatment effectiveness in LND.
View Article and Find Full Text PDF

Given the selection of elderly patients with AML in first complete remission (CR1) the advantage of consolidation with allogeneic hematopoietic cell transplantation (HCT) over chemotherapy is still unclear. Newly diagnosed AML patients in CR1 aged 60-75 years were registered and a donor search initiated. After one consolidation cycle, patients with a matched donor were randomized to HCT with fludarabine/low-dose total body irradiation and cyclosporine/mycophenolate mofetil immunosuppression or conventional non-HCT.

View Article and Find Full Text PDF

Background: Evidence shows that online interventions could prevent depression. However, to improve the effectiveness of preventive online interventions in individuals with subthreshold depression, it is worthwhile to study factors influencing intervention outcomes. Outcome expectancy has been shown to predict treatment outcomes in psychotherapy for depression.

View Article and Find Full Text PDF

Associations Between Glucose Metabolism Measures and Amyloid-β and Tau Load on PET 14 Years Later: Findings From the Framingham Heart Study.

Diabetes Care

October 2024

Alzheimer Center Limburg, School for Mental Health and Neuroscience, Department of Psychiatry & Neuroscience, Maastricht University, Maastricht, the Netherlands.

Article Synopsis
  • The study investigated the relationship between glucose metabolism and the development of tau pathology, a hallmark of Alzheimer's disease, in middle-aged adults without dementia.
  • Researchers analyzed data from 288 participants, examining their fasting plasma glucose and insulin levels and later PET scans for amyloid-β and tau loads.
  • Results showed that elevated plasma glucose correlated with increased tau load after 14 years, particularly in individuals who were not carriers of the APOE ε4 allele, while insulin levels and HOMA-IR did not show significant associations with either amyloid-β or tau.
View Article and Find Full Text PDF

Measurable residual disease (MRD) is detected in approximately a quarter of AML chemotherapy responders, serving as a predictor for relapse and shorter survival. Immunological control of residual disease is suggested to prevent relapse, but the mechanisms involved are not fully understood. We present a peripheral blood single cell immune profiling by mass cytometry using a 42-antibody panel with particular emphasis on markers of cellular immune response.

View Article and Find Full Text PDF

Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we carried out genome-wide cross-population gene-by-short-sleep and long-sleep duration interaction analyses for three blood pressure traits (systolic, diastolic, and pulse pressure) in 811,405 individuals from diverse population groups. We discover 22 novel gene-sleep duration interaction loci for blood pressure, mapped to 23 genes.

View Article and Find Full Text PDF
Article Synopsis
  • Focal Adhesion Kinase (FAK) is an important protein that helps cancer cells stick together, move, grow, and survive, so targeting it could help treat tough cancers like pancreatic cancer.
  • Researchers tested a new series of special compounds and found one that effectively stopped the growth of different pancreatic cancer cells and reduced their movement.
  • In experiments with mice, this compound not only slowed down tumor growth but also showed it wasn’t harmful, making it a strong candidate for future cancer treatments that target FAK.
View Article and Find Full Text PDF

Role of Exercise Hemodynamics in the Prediction of Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers.

Chest

November 2024

School of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France; Service de Pneumologie et Soins Intensifs Respiratoires, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, Paris, France; INSERM UMRS 999, Hôpital Marie Lannelongue, Le Plessis-Robinson, Paris, France. Electronic address:

Background: Exercise hemodynamics are recommended for early detection of pulmonary arterial hypertension (PAH) and have been suggested to be predictive of future development of PAH in high-risk populations such as BMPR2 mutation carriers. However, the optimal exercise hemodynamic screening parameter remains to be determined. Recent data suggest that pulmonary vascular distensibility (α) may serve as a useful parameter for early detection of PAH.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers examined the effectiveness of corneal confocal microscopy (CCM) in detecting small nerve fiber loss in patients with chronic idiopathic axonal polyneuropathy (CIAP) compared to those with painful diabetic neuropathy (PDN) and healthy controls.
  • The study found that while patients with CIAP and PDN had fewer nerve fibers in their skin compared to healthy individuals, CCM results showed no significant differences in corneal nerve parameters for CIAP patients.
  • Ultimately, the findings suggest that CCM is not a reliable method for identifying small nerve fiber loss in patients with CIAP, unlike its use in diagnosing PDN.
View Article and Find Full Text PDF

Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma.

Immunooncol Technol

December 2024

Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht.

Background: The predictive value of tumor-infiltrating lymphocytes (TILs) in immune-related adverse event (irAE) development remains unknown, although an association between tumor immunogenicity and irAEs has been suggested. We investigated the association between TIL abundance in pretreatment primary and metastasis specimens and the subsequent development of severe irAEs.

Patients And Methods: We retrospectively identified patients with advanced cutaneous melanoma who received first-line anti-programmed cell death protein 1 (PD-1) with or without anti-cytotoxic T-lymphocyte associated protein 4 (anti-CTLA-4) from 10 hospitals in the Netherlands.

View Article and Find Full Text PDF

Characterizing Neurobehavioral Dysregulation Among Former American Football Players: Findings From the DIAGNOSE CTE Research Project.

J Neuropsychiatry Clin Neurosci

July 2024

Chronic Traumatic Encephalopathy Center (Pulukuri, Fagle, Trujillo-Rodriguez, van Amerongen, Katz, Alosco, Tripodis, Stern), Graduate Program in Neuroscience (Trujillo-Rodriguez), Department of Neurology (Katz, Alosco, Stern), Alzheimer's Disease Research Center (Alosco, Tripodis, Stern), Department of Neurosurgery and Department of Anatomy and Neurobiology (Stern), Boston University Chobanian and Avedisian School of Medicine, Boston; Department of Neurology, Alzheimer Center Amsterdam, Vrije Universiteit (VU) Amsterdam, VU University Medical Center, and Department of Neurodegeneration, Amsterdam Neuroscience, Amsterdam (van Amerongen); Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas (Bernick); Department of Neurology and the Franke Global Neuroscience Education Center, Barrow Neurological Institute, Phoenix (Geda); Department of Psychiatry and Psychology (Wethe) and Department of Neurology (Adler), Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale; Veterans Affairs Northwest Mental Illness Research, Education, and Clinical Center and Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle (Peskind); Brain Injury Program, Encompass Health Braintree Rehabilitation Hospital, Braintree, Mass. (Katz); Biostatistics and Epidemiology Data Analytics Center (Palmisano) and Department of Biostatistics (Tripodis), Boston University School of Public Health; Departments of Neurology, Population Health, and Ophthalmology, New York University Grossman School of Medicine, New York (Balcer); Banner Alzheimer's Institute, University of Arizona, Translational Genomics Research Institute, Arizona State University, and Arizona Alzheimer's Consortium, Phoenix (Reiman); Departments of Psychiatry and Radiology, Psychiatry Neuroimaging Laboratory, Harvard Medical School, Brigham and Women's Hospital, Boston (Shenton); Department of Brain Health, Chambers-Grundy Center for Transformative Neuroscience, School of Integrated Health Sciences, University of Nevada Las Vegas (Cummings).

Article Synopsis
  • The study investigates neurobehavioral dysregulation (NBD), which includes neuropsychiatric symptoms linked to repetitive head impacts, particularly in former contact sport athletes.
  • Through analyses involving questionnaires from 178 former football players, researchers identified four subconstructs of NBD: explosivity, emotional dyscontrol, impulsivity, and affective lability.
  • The results revealed four symptom profiles among participants, highlighting the complexity of NBD and serving as a basis for future research on its diagnostic criteria and neurobiological aspects.
View Article and Find Full Text PDF

Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab.

NPJ Precis Oncol

July 2024

Université Paris Cité, Dermato-Oncology and CIC AP-HP Hôpital Saint Louis, Cancer Institute APHP, Nord-Université Paris Cité, Paris, France.

In PIVOT IO 001 (NCT03635983), the combination of the investigational interleukin-2 agonist bempegaldesleukin (BEMPEG) with nivolumab (NIVO) had no added clinical benefit over NIVO monotherapy in unresectable/metastatic melanoma. Pre-defined baseline and on-treatment changes in selected biomarkers were analyzed to explore the potential mechanisms underlying the clinical observations. In each treatment arm, higher baseline tumor mutational burden or immune infiltration/inflammation was associated with improved efficacy compared with lower levels.

View Article and Find Full Text PDF

Background: Frailty, an age-related state of reduced physiological reserve, is often associated with lower socio-economic position (SEP). This systematic review synthesised observational studies assessing (i) the association between SEP and frailty prevalence; (ii) how changes in frailty status over time vary by SEP; and (iii) whether the association between frailty and clinical outcomes is modified by SEP.

Methods: We searched three electronic databases from 2001 to 2023.

View Article and Find Full Text PDF

Background And Hypothesis: Recovering from a first psychosis is a highly individual process and requires the person to make sense of their experiences. Clinicians, in turn, need to comprehend these first-person perspectives, creating a mutual sense-making dynamic. Antipsychotic medication is a substantial part of psychosis treatment.

View Article and Find Full Text PDF

Introduction: The presence of tumor-infiltrating lymphocytes (TILs) in melanoma has been linked to survival. Their predictive capability for immune checkpoint inhibition (ICI) response remains uncertain. Therefore, we investigated the association between treatment response and TILs in the largest cohort to date and analyzed if this association was independent of known clinical predictors.

View Article and Find Full Text PDF

Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia.

Neurology

August 2024

From the Alzheimer Center and Department of Neurology (P.J.v.d.V., L.N.C.V., A.C.V.H., H.F.R.-M., S.A.M.S., V.V., W.M.V.D.F.), and Department of Epidemiology and Biostatistics (P.J.v.d.V., J.H., L.N.C.V., J.B., W.M.V.D.F.), Amsterdam Neuroscience, VU University Medical Center; Amsterdam Neuroscience (P.J.v.d.V., L.N.C.V., A.C.V.H., H.F.R.-M., V.V., C.E.T., E.G., W.M.V.D.F.), Neurodegeneration the Netherlands; Division of Clinical Geriatrics (L.N.C.V.), Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden; Medical Psychology (L.N.C.V.), Amsterdam UMC Location AMC, University of Amsterdam; Amsterdam Public Health (L.N.C.V.), Quality of Care, Personalized Medicine; Internal Medicine (H.F.R.-M.), Geriatric Medicine Section, Amsterdam Cardiovascular Sciences Institute, Amsterdam UMC Location VUmc; Department of Clinical, Neuro and Developmental Psychology (S.A.M.S.), Faculty of Movement and Behavioral Sciences, VU University; Department of Radiology & Nuclear Medicine (F.B., E.G.), Amsterdam UMC, Vrije Universiteit, the Netherlands; Queen Square Institute of Neurology and Centre for Medical Image Computing (F.B.), University College London, United Kingdom; and Neurochemistry Laboratory and Biobank (C.E.T.), Department of Clinical Chemistry, Amsterdam Neuroscience, VU University Medical Center, the Netherlands.

Background And Objectives: Cognitive decline rates in Alzheimer disease (AD) vary greatly. Disease-modifying treatments may alter cognitive decline trajectories, rendering their prediction increasingly relevant. We aimed to construct clinically applicable prediction models of cognitive decline in amyloid-positive patients with mild cognitive impairment (MCI) or mild dementia.

View Article and Find Full Text PDF